1. Home
  2. STCN vs QNCX Comparison

STCN vs QNCX Comparison

Compare STCN & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STCN
  • QNCX
  • Stock Information
  • Founded
  • STCN 1986
  • QNCX 2012
  • Country
  • STCN United States
  • QNCX United States
  • Employees
  • STCN N/A
  • QNCX N/A
  • Industry
  • STCN Advertising
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • STCN Consumer Discretionary
  • QNCX Health Care
  • Exchange
  • STCN Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • STCN 78.4M
  • QNCX 92.3M
  • IPO Year
  • STCN 1994
  • QNCX 2019
  • Fundamental
  • Price
  • STCN $12.48
  • QNCX $1.84
  • Analyst Decision
  • STCN
  • QNCX Strong Buy
  • Analyst Count
  • STCN 0
  • QNCX 3
  • Target Price
  • STCN N/A
  • QNCX $9.67
  • AVG Volume (30 Days)
  • STCN 23.1K
  • QNCX 286.7K
  • Earning Date
  • STCN 12-12-2024
  • QNCX 11-13-2024
  • Dividend Yield
  • STCN N/A
  • QNCX N/A
  • EPS Growth
  • STCN 358.74
  • QNCX N/A
  • EPS
  • STCN 3.04
  • QNCX N/A
  • Revenue
  • STCN $183,255,000.00
  • QNCX N/A
  • Revenue This Year
  • STCN N/A
  • QNCX N/A
  • Revenue Next Year
  • STCN N/A
  • QNCX N/A
  • P/E Ratio
  • STCN $4.07
  • QNCX N/A
  • Revenue Growth
  • STCN 2.34
  • QNCX N/A
  • 52 Week Low
  • STCN $7.36
  • QNCX $0.51
  • 52 Week High
  • STCN $13.00
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • STCN 67.87
  • QNCX 49.71
  • Support Level
  • STCN $12.00
  • QNCX $1.91
  • Resistance Level
  • STCN $12.76
  • QNCX $2.09
  • Average True Range (ATR)
  • STCN 0.35
  • QNCX 0.21
  • MACD
  • STCN 0.05
  • QNCX -0.05
  • Stochastic Oscillator
  • STCN 90.00
  • QNCX 19.95

About STCN Steel Connect Inc.

Steel Connect Inc is a diversified holding company. Through its subsidiary, the company provides digital and physical supply chain solutions to many brands across a diverse range of industries, including consumer electronics, telecommunications, computing and storage, software, and others. It also produces and licenses an entitlement management solution powered by its enterprise-class Poetic software, which offers a complete solution for activation, provisioning, entitlement subscription, and data collection from physical goods (connected products) and digital products. The group has an integrated network of facilities throughout North America, Europe, and Asia Pacific. Geographically, it derives key revenue from Mainland China and rest from the United States, Czech, and other regions.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

Share on Social Networks: